Markets
FDA declines to issue specific guidance on health programs' foreign drug imports
A CNBC investigation revealed the proliferation of AFPs, which import prescription drugs from overseas in what U.S. regulators say is a violation of import laws.
Related Articles
Markets
Bull market or trading illusion? Nithin Kamath says India's stock market data is sending mixed signals
Nithin Kamath cautioned that India’s market rally may not reflect a broad bull run, citing weak ca...
Read More → MarketsSebi cautions market players on risks from AI tools like Mythos; sets up task force
India's market regulator Sebi has issued a warning about advanced AI tools used for finding system w...
Read More → MarketsideaForge Technology bulk deal: BNP Paribas buys Rs 39 crore worth shares in this multibagger
Institutional investors, including BNP Paribas, actively acquired stakes in ideaForge Technology thr...
Read More → MarketsUS SEC proposes allowing public companies to opt out of quarterly earnings reports
The SEC proposed ending mandatory quarterly earnings reports for U.S. companies, allowing them to sw...
Read More →